Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michelle Olive, Jason A. Mellad, Leilani E. Beltran, Mingchao Ma, Thomas Cimato, Audrey C. Noguchi, Hong San, Richard Childs, Jason C. Kovacic, Manfred Boehm
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2050–2061 doi:10.1172/JCI31244
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
SDF-1 is localized to the arterial media, and SDF-1 tissue levels are increased in p21–/– mice receiving p21+/+ BM after arterial injury.

(A) SDF-1 staining in uninjured arteries (left panels) and in arteries 3 days after injury (right panels) from p21+/+ (upper panels) and p21–/– (lower panels) mice. VSMCs were identified by smooth muscle α-actin (in green), endothelial cells by CD31 (in green), and inflammatory cells by CD45 (in green). SDF-1 staining is represented in red, and nuclei were counterstained by DAPI (blue). For uninjured and injured groups, left and middle columns represent individual staining; right columns are merged images. Scale bars: 40 μm. (B) Increased arterial tissue SDF-1 levels were observed in p21–/– (blue bars) compared with p21+/+ mice (yellow bars) 3 and 7 days after injury (n = 3; **P < 0.01 versus p21+/+ at same time point). Increased SDF-1 levels were also observed in p21+/+ mice 3 days after injury compared with uninjured p21+/+ mice (n = 3; *P < 0.05). (C) Arterial SDF-1 levels measured 7 days after injury were increased in p21–/– mice that received either p21+/+ (orange bar) or p21–/– (light blue bar) BM compared with p21+/+ mice that received either p21+/+ (yellow bar) or p21–/– (dark blue bar) BM, respectively (n = 5; **P < 0.01).